Innovating Works
REPROGRAM: Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other ch... Academisch Medisch Centrum AMC tramitó un H2020: H2020-PHC-2014-2015 Up to 70% of cardiovascular events are not prevented by current therapeutic regimens. In search for additional, innovative strategies, immun...
2015-12-04 - 2019-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.